Monashee Investment Management LLC Vincerx Pharma, Inc. Transaction History

Monashee Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$0.0 - $0.0 $0 - $0	-200,000 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$0.0 - $0.0 $0 - $0	150,947 Added 307.72%	200,000 $3.23 Million
Q2 2021 Aug 12, 2021	SELL	$0.0 - $27.0 $0 - $1.38 Million	-50,946 Reduced 50.95%	49,053 $637,000
Q1 2021 May 14, 2021	SELL	$22.6 - $31.0 $2.26 Million - $3.1 Million	-100,001 Reduced 50.0%	99,999 $1.93 Million
Q4 2020 Feb 11, 2021	BUY	$12.85 - $19.95 $2.57 Million - $3.99 Million	200,000 New	200,000 $4.18 Million

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.